Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

$45M project to clarify link between stroke, sleep apnea

Researchers at Michigan Medicine in Ann Arbor are funneling an estimated $45 million into a randomized controlled trial they hope will clarify the link between stroke and obstructive sleep apnea.

Thumbnail

Social forms of exercise tied to greatest gains in life expectancy

A new study out of Denmark suggests tennis and other sports with a social element are associated with the greatest improvements in life expectancy.

Thumbnail

Drug-coated balloons as effective as permanent stents for unblocking small arteries

Late-breaking results of a trial presented at the European Society of Cardiology (ESC)’s 2018 meeting in Munich suggest a removable balloon is as effective as a permanent stent in unblocking small arteries. 

Thumbnail

‘We need to take action’: Study finds even low exposure to heavy metals increases risk for CVD

Environmental metals like arsenic, copper, cadmium and mercury could be contributing factors to cardiovascular disease—even at low levels of exposure and in developed countries, Cambridge researchers reported in the BMJ Aug. 29.

Thumbnail

Middle-aged stroke survivors less likely to skip prescribed meds under ACA

More middle-aged stroke survivors are able to afford their preventive medications under the Affordable Care Act (ACA), meaning fewer patients are at an increased risk for cardiovascular conditions like hypertension and diabetes, Reuters reported this week.

Rivaroxaban fails to prevent VTE after hospital discharge

For patients hospitalized with an acute illness, prescribing rivaroxaban for 45 days after discharge doesn’t significantly reduce the risk of venous thromboembolism (VTE) or VTE-related death, according to research presented at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.

Thumbnail

Smoking rates have been falling across the board—except for children under 15

Smoking rates have been dropping steadily in Europe since the 1970s, but, according to new research published in PLOS ONE, 11- to 15-year-olds are using tobacco more frequently.

Thumbnail

AHA pledges $6.5M to overhaul Nebraska’s stroke response system

The American Heart Association (AHA) and American Stroke Association this week pledged $6.5 million to a three-year initiative to improve Nebraska’s stroke response system, the Omaha World-Herald has reported.